Krishnaswamy Yeleswaram insider trades
Open-market stock purchases and sales by Krishnaswamy Yeleswaram, Chief Development Officer at Rapport Therapeutics, Inc, from SEC Form 4 filings since Jun 6, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 25, 2026 | RAPP Rapport Therapeutics, Inc | Sold | $1M |
| Aug 25, 2026 | RAPP Rapport Therapeutics, Inc | Sold | $827K |
| Aug 24, 2026 | RAPP Rapport Therapeutics, Inc | Sold | $658K |
| Aug 19, 2026 | RAPP Rapport Therapeutics, Inc | Sold | $20.2K |
| Apr 17, 2026 | RAPP Rapport Therapeutics, Inc | Sold | $809K |
| Apr 14, 2026 | RAPP Rapport Therapeutics, Inc | Sold | $358K |
| Apr 13, 2026 | RAPP Rapport Therapeutics, Inc | Sold | $321K |
| Apr 10, 2026 | RAPP Rapport Therapeutics, Inc | Sold | $17.5K |
| Apr 8, 2026 | RAPP Rapport Therapeutics, Inc | Sold | $12.6K |
| Mar 25, 2026 | RAPP Rapport Therapeutics, Inc | Sold | $303K |
| Feb 2, 2026 | RAPP Rapport Therapeutics, Inc | Bought (not open market) | — |
| Dec 31, 2025 | RAPP Rapport Therapeutics, Inc | Bought (not open market) | — |
| Dec 31, 2025 | RAPP Rapport Therapeutics, Inc | Sold | $85.3K |
Companies traded
- RAPP Rapport Therapeutics, Inc: 11 sales, last Aug 25, 2026
Get free alerts when Krishnaswamy Yeleswaram files a new trade →